Lensar (LNSR) Share-based Compensation (2019 - 2026)
Lensar (LNSR) reported Share-based Compensation of $690000.0 for Q1 2026, up 5.5% year-over-year from $654000.0 in Q1 2025, and down 20.96% quarter-over-quarter from $873000.0 in Q4 2025.
Lensar (LNSR) Share-based Compensation (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Share-based Compensation data on file, last reported at $690000.0 in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $690000.0, up 5.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 million (up 19.2% YoY), and the FY2025 annual result was $3.1 million, up 17.94% from the prior year.
- Share-based Compensation slipped to $690000.0 in Q1 2026 per LNSR's latest filing, from $873000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $1.8 million in Q2 2023 and troughed at -$1.6 million in Q4 2023.
- A 5-year average of $956000.0 and a median of $850000.0 in 2025 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation plunged 193.22% in 2023, then soared 141.9% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $1.7 million in 2022, then sank by 193.22% to -$1.6 million in 2023, then soared by 141.9% to $662000.0 in 2024, then surged by 31.87% to $873000.0 in 2025, then decreased by 20.96% to $690000.0 in 2026.
- Business Quant data shows LNSR's Share-based Compensation at $690000.0 in Q1 2026, $873000.0 in Q4 2025, and $850000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | 690,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 690,000.00 |
| Mar 31, 2026 | 690,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Mar 31, 2025 | 654,000.00 |
| Mar 31, 2025 | 654,000.00 |
| Dec 31, 2024 | 662,000.00 |
| Dec 31, 2024 | 662,000.00 |
| Sep 30, 2024 | 668,000.00 |
| Sep 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 683,000.00 |
| Jun 30, 2024 | 683,000.00 |
| Mar 31, 2024 | 652,000.00 |
| Mar 31, 2024 | 652,000.00 |
| Dec 31, 2023 | -1.58 Mn |
| Dec 31, 2023 | -1.58 Mn |